Brooklyn Investment Group Buys New Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Brooklyn Investment Group purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 1,911 shares of the company’s stock, valued at approximately $179,000.

Other institutional investors have also added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. raised its stake in shares of GE HealthCare Technologies by 17.0% in the first quarter. B. Riley Wealth Advisors Inc. now owns 7,404 shares of the company’s stock worth $673,000 after purchasing an additional 1,074 shares during the last quarter. Hancock Whitney Corp increased its position in shares of GE HealthCare Technologies by 1.6% during the first quarter. Hancock Whitney Corp now owns 17,595 shares of the company’s stock valued at $1,600,000 after acquiring an additional 279 shares during the last quarter. Plato Investment Management Ltd purchased a new stake in shares of GE HealthCare Technologies during the first quarter valued at approximately $206,000. New Covenant Trust Company N.A. purchased a new stake in shares of GE HealthCare Technologies during the first quarter valued at approximately $47,000. Finally, Sanibel Captiva Trust Company Inc. increased its position in shares of GE HealthCare Technologies by 7.9% during the first quarter. Sanibel Captiva Trust Company Inc. now owns 3,114 shares of the company’s stock valued at $283,000 after acquiring an additional 228 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 0.6 %

GEHC opened at $83.00 on Thursday. The company has a market cap of $37.92 billion, a P/E ratio of 22.80, a P/E/G ratio of 2.96 and a beta of 1.24. The business’s 50-day moving average price is $88.19 and its 200-day moving average price is $83.61. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 12 month low of $66.39 and a 12 month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.99 earnings per share. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.30%.

Analysts Set New Price Targets

GEHC has been the subject of several research reports. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the company from $84.00 to $74.00 in a report on Thursday, September 26th. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Wednesday, September 18th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Finally, Evercore ISI raised their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $94.36.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.